Differentiation Therapy and Advances in Cancer
Suzhou Dushu Lake Conference Center
October 20-24, 2012
Abstract deadline extended to August 31, 2012

Schedule Overview

Organized by:
Zhu Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Saijuan Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Samuel Waxman, The Mount Sinai Medical Center, USA

We are pleased to announce Cold Spring Harbor Asia/The 13th International Conference on Differentiation Therapy: Differentiation Therapy and Advances in Cancer which will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai. This conference will begin in the afternoon of Saturday October 20, and will conclude after lunch on wednesday Oct 24, 2012.

This Cold Spring Harbor conference is merged with the biennial International Conference on Differentiation Therapy (ICDT), which has been recognized as one of the highest-level international scientific meetings in the field of cancer research. Differentiation therapy, which has already shown a targeted, cancer selective therapeutic effect that turned acute promyelocytic leukemia from highly fatal to curable, represents a breakthrough in cancer therapies. This conference is arranged to reflect the most updated advancement in differentiation cancer therapies and the forefront of cancer research. We will also select short talks from openly submitted abstracts and organize workshops pertinent to the subjects of the conference to ensure the maximum amount of interaction and discussion between lecturers and participants.

Major Topics:
- Epigenetics and Epigenomics of Cancer
- Genetics and Genomics of Cancer
- Cancer stem cells and novel targets
- Animal models and novel targets
- Targeted Therapies: Present and Future
- Differentiation Therapy of APL and Beyond

Keynote Speakers:
Zhu Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Abstract title: TBA
Stephen Baylin, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, United States
Abstract title: The Era of the Cancer Epigenome – Dissecting the Biological and Translational Implications
Carlo Croce, Ohio State University, USA
Abstract title: Causes and consequences of microRNA dysregulation in cancer
Samuel Waxman, The Mount Sinai Medical Center, USA
Abstract title: Targeted Epigenetic Therapy of Triple-Negative Breast Cancer

Invited Speakers:
Saijuan Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, CHINA
Abstract title: Genetic and epigenetic changes contributing to leukemogenesis and prognostic impact in acute myeloid leukemia
John Crispino, Northwestern University, USA
Abstract title: Inducers of Megakaryocyte Polyploidization as Novel Differentiation Therapy for Acute Megakaryocytic Leukemia
Riccardo Dalla-Favera, Columbia University, USA
Abstract title: Therapeutic insights from the analysis of the genome of Diffuse Large B Cell Lymphoma
Hugues de Thé, Université Paris 7/CNRS, France
Abstract title: MODELLING APL PATHOGENESIS THROUGH THERAPY RESPONSE
Tariq Enver, UCL Cancer Institute, UNITED KINGDOM
Abstract title: Unravelling the genetic basis of relapse in childhood ALL
Lorraine Gudas, Weill Cornell Medical College, USA
Abstract title: RETINOIDS REGULATE EPIGENETIC CHANGES DURING STEM CELL DIFFERENTIATION
Zeguang Han, Shanghai Jiaotong University, China
Abstract title: Functional genomic studies provide insights into the pathogenesis of hepatitis B virus-associated hepatocellular carcinoma
Gunther Hartmann, Universitätsklinikum Bonn, GERMANY
Abstract title: RIG-I in immune tolerance of self RNA and cancer therapy
Scott Hiebert, Vanderbilt University, USA
Abstract title: Hdac3 as a potential target for differentiation therapy in acute leukemia
Shai Izraeli, Sheba Medical Center, ISRAEL
Abstract title: "Hematopoietic differentiation and lineage determination in childhood leukemia: Down Syndrome as a model"
Phillip Koeffler, Cancer Science Institute of Singapore, NUS
Abstract title: LNK: linking the accelerator to the brake
Xin Lu, Ludwig Institute For Cancer Research Ltd, UK
Abstract title: Restoring the tumour suppressive function of p53 in human melanoma cells
Ari Melnick, Weill Cornell Medical College, USA
Abstract title: Epigenetic Basis of Acute Leukemia
Tomoki Naoe, Nagoya University Graduate School of Medicine, JAPAN
Abstract title:The efficacy and safety of a series of treatment from arsenic trioxide therapy to autologous transplantation for relapsed APL patients: a prospective JALSG APL205R study
Benjamin Neel, Ontario Cancer Institute/MaRs Centre, CANADA
Abstract title: Ptpn11 Deficiency in A Novel Cartilage Stem/Progenitor Cell Causes Metachondromatosis by Activating the Hedgehog Pathway.
Ryuzo Ohno, Aichi Cancer Center Hospital, JAPAN
Abstract title: Treatment of Elderly Patients with Acute Promyelocytic Leukemia (APL)
Yang Shi, Harvard Medical School, USA
Abstract title: Histone methylation regulation in the DNA damage response
Martin Tallman, Memorial Sloan-Kettering Cancer Center, USA
Abstract title: Seminal Observations in APL from the North American Intergroup and Contemporary Therapeutic Strategies
Daniel Tenen, Harvard Medical School, USA
Abstract title: Regulation of myeloid transcription factors and DNA methylation by noncoding RNAs
Jun Wang, BIG-Shenzhen, China
Abstract title: Revealing the process of cell evolution and innovating personalized treatment
Yue Xiong, University of North Carolina at Chapel Hill, USA
Abstract title: Oncometabolites in epigenetic control and cancer
Yixin Zeng, Peking Union Medical College, China
Abstract title:TBA
Qimin Zhan, Peking Union Meidcal College, China
Abstract title:TBA
Ming-Ming Zhou, Mount Sinai School of Medicine, USA
Abstract title:TBA

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

Fellowship:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $200-$500) awards. For more details, please visit Stipends

We look forward to seeing you at Suzhou in October.

Package Content:

Please kindly note:

1. The early & normal price will be available if the full payment is finished before the exact due date.
For USD participants, we will automatically change your package price to the update one if we could not successfully charge the full payment from your registered credit card before the deadline.
For CNY participants, we will automatically change your package price to the update one if our bank account could not receive your full payment by wire transfer before the deadline.

2. For Student Package registered participants, please add your roommate requirement during the online registration. Otherwise, we’ll assign you a roommate among other student participants.

3. For late registrations, your housing & registration materials may not be guaranteed since the order is usually made in advance.

4. Please inform us your request on extra day (USD 80/CNY 500 per day) and food (vegetarian, kosher…etc.) during the online registration or email us as early as possible so that we could make relevant arrangement accordingly.

5.We offer CSHA endowed student package for graduate students (student ID is required). This special offer only includes the meeting session pass. Housing, food and social activities are not included in the package.

Currency converter